Form S-1/A CATALYST BIOSCIENCES,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- Wall St climbs after August inflation report, oil price slide
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but on track for 8% weekly gain on supply concerns; US diesel hits record high
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- White House copper tariff plan stalls amid affordability concerns, sources say
- Micron's Taiwan workers to get rewards worth up to 68 months of pay
- Crude Inventory 0.4M Barrels Last Week - EIA
- Vertiv shares drop on acquisition skepticism, AI pullback
- S&P 500, Dow futures attempt recovery ahead of inflation report
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Catalyst Biosciences (CBIO) Prices Common Stock and Warrant Offering for Gross Proceeds of $18M
April 7, 2017 8:40 AM EDTCatalyst Biosciences, Inc. (NASDAQ: CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced the pricing of an underwritten public offering of units for gross proceeds of $18 million, prior to deducting underwriting discounts and commissions and offering expenses payable by Catalyst.
The offering is comprised of Class A Units, priced at a public offering price of $5.00 per unit, with each unit consisting of one share of common stock and a five-year warrant (each, a warrant) to purchase one-half share of common stock with an... More
Catalyst Biosciences (CBIO) Set to Open Lower
April 7, 2017 6:46 AM EDTCatalyst Biosciences (NASDAQ: CBIO) was set to open sharply lower Friday morning following an effective notice from the SEC regarding its recent S-1.
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Notice of EffectivenessEffectiveness Date:April 6, 2017 5:00 P.M.Form:S-1CIK:0001124105Company Name:CATALYST BIOSCIENCES, INC.File Number:333-216663... More